Eu2P expands to North America with Am2P!

We are delighted to launch Am2P, the American Program in Pharmacovigilance!
Am2P offers academic Certificates and Short Courses in drug safety that target the North America pharma industry, according to the needs of the International Society of Pharmacovigilance (ISoP). These courses have been developed in collaboration with the North American Chapter of the ISoP (NASoP) instructors and benefit from existing Eu2P course materials, education technology, and academic accreditation background.
Interested in North American PV courses? Please visit the Am2P website!

Am2PCreated by Eu2P and NASoP

Where does Eu2P come from, where it is going towards? Read last IMI news

Eu2P has offered a growing suite of certified drug-safety education courses since 2009, with renewed interest in the discipline spurred by COVID19. They are now expanding beyond the EU.
Drug safety academic programme expands to North America — Innovative Medicines Initiative, June 2021

Eu2P students' feedback

2019-2020 students have completed their studies. Read what they (and former Eu2P alumni students) think about their Eu2P training experience!

What do students think about Eu2P

New: Eu2P launches a first Short Course in Spanish

register anytime

50% OFF on the first Spanish Short Course in epidemiology launched by Eu2P! Register now to Epidemiologia para los no epidemiologos and be certified in epidemiology in your Spanish mother tongue.
¡50% de descuento en el primer curso corto español en epidemiología lanzado por Eu2P! Regístrese ahora en Epidemiologia para los no epidemiologos y certifíquese en epidemiología en su lengua materna española

More info

Epidemiologia para los no epidemiologos and be certified in epidemiology

Eu2P's active despite COVID19

Despite the tense situation we all have to face as regards the coronavirus crisis, please be informed that all Eu2P online applications and running course programmes are maintained and active.
The Eu2P office team is available as usual for any assistance or need: please use either email or temporary new phone number +33 630290029 as we are not in our currently-closed university campus' office.

Best regards,
The Eu2P Central Office






Learn from
world-class experts

Eu2P training programmes have been designed by a unique consortium of Universities, Regulatory Agencies and Pharmaceutical Companies.
This unique network has brought and invited the best experts from world industry, CROs, health authorities, professional societies and media to widen understanding, emphasize cultural specificities and therefore meet the job market needs.

Eu2P Partners

Study online
at your own pace

Eu2P has designed flexible modular programmes to ease access and study progression for people with limited time availabilities such as healthcare professionals.

Healthcare Professionals' guide

All Eu2P courses are delivered online so that students can access anytime from anywhere to learning contents and activities!

Eu2P eLearning

Get valuable and
recognized awards

Eu2P programmes delivers Master, PhD and Certificate diplomas that are jointly awarded by Eu2P academic partners and recognized by all Eu2P regulatory and industrial partners!

Certificates  Master  PhD

Eu2P also delivers Short Courses Certificates Of Achievement to demonstrate your Continuing Education progress.

Short Courses


They trust Eu2P

Companies offers


Former students' words...


  • Excellent programme! Incomparable opportunity to learn from leading experts in the area.

    Andrius Bacevicius
    • Andrius Bacevicius
    • Clinical Development Physician
  • For students and professionals who want to build a career in Pharmacovigilance and Pharmacoepidemiology.

    Manoa Razafimanantsoa
    • Manoa Razafimanantsoa
    • Drug Safety Associate
  • I highly recommend Eu2P because of the well balanced mix of various perspectives that you can rarely find in other programmes.

    Alexandra Barbulescu-Pacurariu
    • Alexandra Barbulescu-Pacurariu
    • Pharmacovigilance Assessor

More testimonials


Powered By

Eu2P Executive Board partners

Created By

Eu2P project consortium partners